FLASH NEWS LIVE

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Lowered by Stifel Nicolaus

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Lowered by Stifel Nicolaus

MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, MarketBeat Ratings reports. They presently have a $13.00 price o…

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.